Page 278 - அமெரிக்கன் கல்லூரி ஆஃப் மகப்பேறியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

What pregnant, breastfeeding people should know about COVID-19 vaccines

Blue Planet Studio/iStockBy KATIE KINDELAN, GMA(NEW YORK) As the COVID-19 vaccine becomes more widely available to people younger than 65 and outside of the health care community, it is raising questions for breastfeeding and pregnant people who must decide if the vaccine is right for them.Pfizer and BioNTech became the first vaccine maker to evaluate their COVID-19 vaccine in pregnant women when they announced a new trial Thursday.Their vaccine, along with Moderna's, are the two mRNA vaccines currently available in the United States after being granted Emergency Use Authorization by the Food and Drug Administration.Moderna has not yet publicly released a timeline for including pregnant people in clinical trials.Here are six things pregnant and breastfeeding people should consider to make an informed decision about the COVID-19 vaccine.1. What is the science behind the COVID-19 vaccine?Both the Pfizer and Moderna vaccines use mRNA technology, which does not enter the nucleus of

United statesUnited kingdomSouth africaRuth fadenStephen hahnJennifer ashtonEric straussJohns hopkins berman institute of bioethicsWorld health organizationDrug administrationAdvisory committee on immunization practicesAmerican college of obstetriciansSociety for maternalBlue planetEmergency use authorizationAmerican college

Volpara Health acquires fellow breast cancer prevention company CRA Health

Volpara Health acquires fellow breast cancer prevention company CRA Health
mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.

United statesRalph highnamAmerican college of obstetriciansDrug administrationAmerican cancer societyVolpara healthMassachusetts generalAmerican cancerAmerican collegeMedical visionஒன்றுபட்டது மாநிலங்களில்அமெரிக்கன் கல்லூரி ஆஃப் மகப்பேறியல்அமெரிக்கன் புற்றுநோய் சமூகம்மாசசூசெட்ஸ் ஜநரல்அமெரிக்கன் புற்றுநோய்அமெரிக்கன் கல்லூரி

GOP-controlled Legislature advancing anti-abortion measures

PHOENIX (AP) Republicans in the Arizona Legislature advanced a pair of bills Thursday.

United statesSouth carolinaMartin quezadaNancy bartoWendy rogersJulie kwatraWalt blackmanSenate appropriations committeeUs supreme courtAmerican college of obstetriciansHuman coalitionFirst amendmentAmerican collegeMichelle udallScottsdale ob gynNorth america

Pfizer to begin Covid vaccine clinical trial in pregnant women

Pfizer to begin Covid vaccine clinical trial in pregnant women Erika Edwards © Provided by NBC News Pfizer-BioNTech said Thursday that it is beginning clinical trials of its Covid-19 vaccine in pregnant women, the first such trials to include expectant mothers in the U.S. The drugmaker aims to enroll about 4,000 pregnant women in the trials, which will include participants in the U.S. as well as Argentina, Brazil, Canada, Chile, Mozambique, South Africa, Spain and the U.K. Women over 18 and who are 24 to 34 weeks into their pregnancy will be eligible. The first doses will be administered in the U.S., Pfizer said.

North carolinaUnited statesSouth africaStacey stewartWilliam gruberBrenna hughesCenters for diseaseVaccine clinical research at pfizerAmerican college of obstetriciansDuke health in durhamMicrosoft newsDuke healthAmerican collegeVaccine clinical researchDisease controlவடக்கு கரோலினா

Pfizer launches COVID-19 vaccine trial in pregnant women

Pfizer launches COVID-19 vaccine trial in pregnant women TODAY 2/18/2021 © Provided by TODAY Pfizer-BioNTech said Thursday that it is beginning clinical trials of its COVID-19 vaccine in pregnant women, the first such trials to include expectant mothers in the U.S. The drugmaker aims to enroll about 4,000 pregnant women in the trials, which will include participants in the U.S. as well as Argentina, Brazil, Canada, Chile, Mozambique, South Africa, Spain and the U.K. Women over 18 and who are 24 to 34 weeks into their pregnancy will be eligible. The first doses will be administered in the U.S., Pfizer said. Dr. Brenna Hughes, a maternal-fetal medicine specialist at Duke Health in Durham, North Carolina, said she absolutely applauds Pfizer s study of its vaccine in pregnant women.

North carolinaUnited statesSouth africaStacey stewartWilliam gruberBrenna hughesCenters for diseaseVaccine clinical research at pfizerAmerican college of obstetriciansDuke health in durhamDuke healthAmerican collegeVaccine clinical researchDisease controlவடக்கு கரோலினாஒன்றுபட்டது மாநிலங்களில்